Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bracco Imaging’s portfolio includes several FDA-approved commercial products across all major diagnostic modalities—X-ray/CT, MRI, ultrasound, nuclear medicine—with ongoing R&D in new contrast media and molecular/nuclear imaging solutions. The acquisition of Blue Earth Diagnostics expanded their commercial offerings into novel PET tracers for prostate cancer recurrence detection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bracco Imaging.